Alpha Tau Medical Ltd. (DRTS): R&D Expense
$32.06M
Year ended 2025-12-31
+15.4%
3-year compound annual growth
+33.6%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $32.06M | +18.7% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $27.02M | +2.3% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $26.42M | +26.5% | 2026-03-09, From 2023-01-01 |
| 2022-12-31 | $20.89M | +82.5% | 2025-03-12, From 2022-01-01 |
| 2021-12-31 | $11.45M | +51.7% | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | $7.54M | +13.7% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $6.64M | n/a | 2022-03-28, From 2019-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Alpha Tau Medical Ltd. (DRTS) | 2025-12-31 | $32.06M | +18.7% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $27.89M | +17.9% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $11.13M | 0.0% |
| Iradimed Corp (IRMD) | 2025-12-31 | $2.98M | +5.0% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $13.79M | -43.0% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $13.90M | +12.1% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $58.19M | +35.9% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $14.61M | -18.8% |
Compare DRTS, NPCE, CVRX, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗